Imunon, Inc. Investment Income, Interest
Imunon, Inc. (IMNN) reported Investment Income, Interest of $23.73 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2014-08-07
- Imunon, Inc. investment income, interest for the quarter ending 2014-06-30 was $23.73K, a 64.65% decline year-over-year.
- Imunon, Inc. investment income, interest for the quarter ending 2014-03-31 was $7.02K, a 57.62% decline year-over-year.
- Imunon, Inc. investment income, interest for the quarter ending 2013-12-31 was -$240.97K.
- Imunon, Inc. investment income, interest for the quarter ending 2013-09-30 was $144.53K.
- Imunon, Inc. investment income, interest for fiscal 2013 was -$12.74K, a 124.36% decline from fiscal 2012.
- Imunon, Inc. investment income, interest for fiscal 2012 was $52.32K, a 69.94% decline from fiscal 2011.
- Imunon, Inc. investment income, interest for fiscal 2011 was $174.06K, a 439.08% increase from fiscal 2010.
- Imunon, Inc. investment income, interest for fiscal 2010 was $32.29K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2014-06-30 | $23.73K 10-Q · filed 2014-08-07 | $30.75K 10-Q · filed 2014-08-07 | -$210.22K derived: sum of 3 quarters · filed 2014-08-07 | -$65.69K derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-31 | $7.02K 10-Q · filed 2014-05-08 | -$233.95K derived: sum of 2 quarters · filed 2014-05-08 | -$89.42K derived: sum of 3 quarters · filed 2014-05-08 | -$22.29K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-12-31 | -$240.97K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$96.44K derived: sum of 2 quarters · filed 2014-03-13 | -$29.31K derived: sum of 3 quarters · filed 2014-08-07 | -$12.74K 10-K · filed 2014-03-13 |
| 2013-09-30 | $144.53K 10-Q · filed 2013-11-12 | $211.66K derived: sum of 2 quarters · filed 2014-08-07 | $228.23K 10-Q · filed 2013-11-12 | $218.72K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-06-30 | $67.13K 10-Q · filed 2014-08-07 | $83.69K 10-Q · filed 2014-08-07 | $74.19K derived: sum of 3 quarters · filed 2014-08-07 | $68.61K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $16.56K 10-Q · filed 2014-05-08 | $7.06K derived: sum of 2 quarters · filed 2014-05-08 | $1.48K derived: sum of 3 quarters · filed 2014-05-08 | $63.55K derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | -$9.51K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$15.09K derived: sum of 2 quarters · filed 2014-03-13 | $46.99K derived: sum of 3 quarters · filed 2014-03-13 | $52.32K 10-K · filed 2014-03-13 |
| 2012-09-30 | -$5.58K 10-Q · filed 2013-11-12 | $56.49K derived: sum of 2 quarters · filed 2013-11-12 | $61.83K 10-Q · filed 2013-11-12 | $208.98K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $62.08K 10-Q · filed 2013-08-08 | $67.41K 10-Q · filed 2013-08-08 | $214.56K derived: sum of 3 quarters · filed 2014-03-13 | $240.91K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $5.33K 10-Q · filed 2013-05-09 | $152.49K derived: sum of 2 quarters · filed 2014-03-13 | $178.83K derived: sum of 3 quarters · filed 2014-03-13 | $178.93K derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $147.15K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $173.50K derived: sum of 2 quarters · filed 2014-03-13 | $173.60K derived: sum of 3 quarters · filed 2014-03-13 | $174.06K 10-K · filed 2014-03-13 |
| 2011-09-30 | $26.35K 10-Q · filed 2012-11-09 | $26.44K derived: sum of 2 quarters · filed 2012-11-09 | $26.91K 10-Q · filed 2012-11-09 | $28.46K derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $97.00 10-Q · filed 2012-08-14 | $564.00 10-Q · filed 2012-08-14 | $2.11K derived: sum of 3 quarters · filed 2012-08-14 | $10.70K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $467.00 10-Q · filed 2012-05-15 | $2.02K derived: sum of 2 quarters · filed 2012-05-15 | $10.61K derived: sum of 3 quarters · filed 2012-05-15 | $24.56K derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $1.55K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $10.14K derived: sum of 2 quarters · filed 2012-03-15 | $24.09K derived: sum of 3 quarters · filed 2012-03-15 | $32.29K 10-K · filed 2012-03-15 |
| 2010-09-30 | $8.59K 10-Q · filed 2011-11-10 | $22.54K derived: sum of 2 quarters · filed 2011-11-10 | $30.74K 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $13.95K 10-Q · filed 2011-08-09 | $22.15K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |